Research Catalog
High-purity, structurally verified peptide sequences for advanced laboratory and pre-clinical applications.

Semax is a synthetic heptapeptide derived from the adrenocorticotropic hormone (ACTH) fragment 4-10 with modifications. With the molecular formula C₃₇H₅₁N₉O₁₀ and a molecular weight of 812.9 g/mol (CA...
Lab Verified
Clinical Grade
PMID Cited
Published preclinical research has characterized the following molecular pathways and receptor interactions for Semax.
Semax increases brain-derived neurotrophic factor expression and activates TrkB receptors in neuronal cultures.
Research demonstrates Semax modulates expression of genes involved in neuroplasticity and neurotrophic factor production.
Preclinical studies have characterized the molecular properties and receptor binding profiles of Semax in standardized assay systems.
Structure-activity relationship studies have examined the functional domains and binding characteristics of Semax in cell-free and cell-based systems.
RESEARCH USE ONLY: This compound is intended exclusively for in vitro laboratory research. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. Not evaluated by the FDA. Must be 21+ to purchase.
CognitiveN/A (complex porcine peptide mixture) · Variable (low-MW neuropeptides ≤10,000 Da)
For in vitro research use only. Not for human consumption.
CognitiveC35H48N10O15 · 848.82 g/mol
For in vitro research use only. Not for human consumption.
CognitiveC14H22N4O9 · 390.35 g/mol
For in vitro research use only. Not for human consumption.